Xtant Medical Holdings, Inc.XTNTNYSE
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank100
5Y CAGR+26.9%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

5Y CAGR
+26.9%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
3.3x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM8.19%+221.9%
2024-6.72%-220.9%
20235.56%+159.4%
2022-9.36%-105.9%
2021-4.55%-282.6%
20202.49%+89.5%
20191.31%+101.8%
2018-75.09%-111.6%
2017-35.48%-52082.6%
20160.07%-